The mission of the Pharmacogenomics Research Network (PGRN) is to catalyze and lead research in precision medicine for the discovery and translation of genomic variation influencing therapeutic and adverse drug effects.​​
PGRN Forum launched!
A new place where you can learn, discuss, and share relevant experiences in PGx fields
Showcase your PGx projects!
Apply to present your PGx research project(s) with a custom-built webpage on pgrn.org
Funding opportunities from NHGRI
towards translating genomic & genetic research throughout 2019

Highlights

Congratulations to the 2019 PGRN Poster Session at ASHG award winners


​Winners:
Clara Amorosi, University of Washington  ​
Tanima De, Northwestern University    
​Cameron D. Thomas, University of Florida  

​Honorable Mentions: 
Abhinav Grover, University of California, Irvine    
Erika N. Scott, University of British Columbia    
Yiwei Liu, St. Jude Children's Research Hospital    
Ednalise Santiago, University of Puerto Rico - Med Sci Campus  
​The PGRN Poster Session & Reception was held on October 17th, 2019 during the 2019 ASHG Annual Meeting in Houston.

PGx Newsfeed

Upcoming PGRN events

PGRN Hub Corner
PGRN.org disseminates information about the PGRN network, pharmacogenomics research, and PGx activities to unify and organize our network community. We encourage everyone to explore the site to see the resources we have to offer, such as the Tools page.

March 2020 Featured Investigator

Jeffrey R. Strawn, MD, FAACAP

Associate Professor of Psychiatry & Pediatrics | Associate Vice Chair of Research
UC Department of Psychiatry & Behavioral Neuroscience
Dr. Strawn is an Associate Professor of Psychiatry at the University of Cincinnati and at Cincinnati Children’s Hospital and Director of the Anxiety Disorders Research Program. He is board-certified in general as well as child and adolescent psychiatry. Dr. Strawn completed general psychiatry residency training at the University of Cincinnati and a clinical fellowship in child and adolescent psychiatry at Cincinnati Children’s Hospital.

His current research involves clinical trials in mood and anxiety disorders as well as the identification of risk factors for these conditions. His research focuses on the pathophysiology and psychopharmacology of anxiety and related disorders..